Fund Overview
Key Personnel
Activity Summary — 2025 Q4
Top Buys
| Stock | % Impact |
|---|---|
| KNF KNIFE RIVER COR.. | +4.28% |
| TNDM TANDEM DIABETES.. | +3.70% |
| FLS FLOWSERVE CORP.. | +3.48% |
| DLO DLOCAL LTD.. | +2.56% |
| GMED GLOBUS MED INC.. | +1.58% |
| WHD CACTUS INC.. | +1.54% |
Top Sells
| Stock | % Impact |
|---|---|
| GTLS CHART INDS INC.. Sold All 😨 Was: 2.64% | -2.29% |
| SLB SCHLUMBERGER LT.. Sold All 😨 Was: 2.45% | -2.13% |
| SKIL SKILLSOFT CORP.. | -0.50% |
| ITT ITT INC.. | -0.43% |
| GTES GATES INDL CORP.. | -0.37% |
| MHK MOHAWK INDS INC.. | -0.36% |
Activity Summary
Sector Allocation Trends
Holdings Analysis
Positions Dynamics
Portfolio Analytics — Latest
Paradice Investment Management LLC risk dashboard covering volatility, beta, value-at-risk, drawdowns, concentration, factor tilts, benchmark comparison, and stress testing for the latest disclosed portfolio.
Tracking institutional benchmark deviation
Best Strategy vs. Benchmarks
Strategy Backtester: Paradice Investment Management LLC
Replicate top holdings performance • Compare vs benchmarks • Optimize N
Find the best N! Test multiple portfolio sizes at once to discover the optimal configuration.
Risk insights! Identify periods when the fund lagged the benchmark – critical for timing entries.
⏱ Run Backtest
Liquid Glass Edition
👆 Click the button to launch tickers!
Backtesting Paradice Investment Management LLC's top 10 holdings against SPY identified 30 underperformance periods. Worst drawdown: 2024-09 – 2025-07 (-49.4% vs SPY, 11 quarters).
The ticker-level breakdown shows how each of Paradice Investment Management LLC's top holdings contributed to portfolio returns quarter by quarter. Best historical picks since first purchase: GMED (2023, +74%), NVST (2020, +45%), GNRC (2025, +39%) .
Disclaimer: 13Foresight is not a registered investment adviser, broker-dealer, or financial planner. All information on this site is provided solely for informational and educational purposes and does not constitute investment advice, a solicitation, or a recommendation to buy or sell any security. Portfolio backtests shown on this page are hypothetical and simulated — they do not represent actual trading results and were constructed with the benefit of hindsight. Actual results would differ materially. 13F filings disclose only long equity positions valued above $10,000, submitted up to 45 days after quarter-end; they do not capture short positions, options, bonds, cash, private investments, or non-U.S. securities. A fund's backtest performance may not reflect its actual returns, as managers frequently generate alpha through strategies not visible in 13F data. Past performance is not indicative of future results. All data sourced from public SEC EDGAR filings. Use at your own risk. Full Terms of Use.